TargetMol

N-Retinoylleucine

Product Code:
 
TAR-T33733
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33733-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33733-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33733-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
N-Retinoylleucine has less toxicity and has similar immunological effects as retinoic acid.
CAS:
110769-97-6
Formula:
C26H39NO3
Molecular Weight:
413.602
Purity:
0.98
SMILES:
CC(C)C[C@H](NC(=O)C=C(/C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C)C(O)=O

References

Kochhar DM, Shealy YF, Penner JD, Jiang H. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity. Teratology. 1992 Feb;45(2):175-85. PubMed PMID: 1615427. Lindamood C 3rd, Dillehay DL, Lamon EW, Giles HD, Shealy YF, Sani BP, Hill DL. Toxicologic and immunologic evaluations of N-(all-trans-retinoyl)-DL-leucine and N-(all-trans-retinoyl)glycine. Toxicol Appl Pharmacol. 1988 Nov;96(2):279-95. PubMed PMID: 3194915.